New antibiotic safety study for kidney patients launches
NCT ID NCT07104162
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 23 times
Summary
This early-stage study is testing a new antibiotic called Cefiderocol/Xeruborbactam in 40 adults with different levels of kidney function, including those on dialysis. The main goal is to see how safe the drug is and how the body processes it after a single dose. This information will help doctors decide the right dose for people with kidney problems who have bacterial infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
Contact
Contact
-
University of Miami Clinical Pharmacology
RECRUITINGMiami, Florida, 33136, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.